MPN-469 Rusfertide (PTG-300) Treatment Interruption Reverses Hematological Gains and Upon Reinitiation, Restoration of Clinical Benefit Observed in Patients With Polycythemia Vera

Naveen Pemmaraju, Andrew Kuykendall, Marina Kremyanskaya, Yelena Ginzburg, Ellen Ritchie, Jason Gotlib, Aaron Gerds, Jeanne Palmer, Frank Valone, Paula O'Connor, Nishit Modi, Suneel Gupta, Ronald Hoffman, Srdan Verstovsek

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'MPN-469 Rusfertide (PTG-300) Treatment Interruption Reverses Hematological Gains and Upon Reinitiation, Restoration of Clinical Benefit Observed in Patients With Polycythemia Vera'. Together they form a unique fingerprint.

Medicine & Life Sciences